Bioscience Biotechnology Research Communications

An International  Peer Reviewed Refereed Open Access Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Durgadatta Meher

Assistant Professor, Department of Genetics and Plant Breeding, M.S.Swaminathan School of Agriculture,
Centurion University of Technology and Management, Paralakhemundi, Odisha, India

DOI:

Article Publishing History

Received: 14/10/2020

Accepted After Revision: 28/12/2020

ABSTRACT:

Genome editing is an approach in which a specific target DNA sequence of the genome is altered by adding, removing, or replacing DNA bases. Recently, genome editing based on the bacterial defence mechanism.CRISPR/Cas9 has emerged as an easily applicable and reliable laboratory tool. Combining organoids and CRISPR/Cas9 creates exciting new opportunities to study organ development and human disease in vitro. The potential applications of CRISPR in organoids are only beginning to be explored. The development of antibiotic resistance in bacteria is a major public health threat. Infection rates of resistant pathogens continue to rise against nearly all antimicrobials, which have led to development of different strategies to combat the antimicrobial resistance. In this review, we discuss how the newly popular CRISPR-cas system has been applied to combat antibiotic resistance in both extracellular and intracellular pathogens. Recent investigations have revealed the implications of the CRISPR–Cas system as a promising tool for targeted genetic modifications in plants. This technology is likely to be more commonly adopted in plant functional genomics studies and crop improvement in the near future.

KEYWORDS:

CRISPR, Cas9, Genome Editing, Sgrna.

Download this article as:

Copy the following to cite this article:


Copy the following to cite this URL: